FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Public Meeting on GDUFA Goals

Federal Register notice: FDA announces a virtual public meeting entitled Generic Drug User Fee Amendments (GDUFA) of 2017.

Federal Register

FDA Covid-19 Guidances Available

Federal Register notice: FDA makes available guidance documents related to the Covid19 public health emergency.

Human Drugs

Curativa Bay Warning Letter on Covid Spray

FDA sends Curativa Bay (Clearwater, FL) a Warning Letter after reviewing the companys Web site and citing its Advanced Hypochlorous Skin Spray over mi...

Human Drugs

Chiasma NDA Approved for Acromegaly

FDA approves a Chiasma NDA for Mycapssa (octreotide) capsules for long-term maintenance treatment in certain acromegaly patients.

Medical Devices

Guide on Device Inspection Process

FDA posts a final guidance entitled Review and Update of Device Establishment Inspection Processes and Standards.

FDA General

FDA WEBVIEW CLOSED JULY 4TH WEEK

In observance of the Fourth of July (Independence Day) holiday in the U.S., FDA Webview closes its news operations until Monday, July 6.

Medical Devices

Colored Contact Lenses Recalled

Chengdu Ai Qin E-commerce Co. recalls its colored contact lenses after FDA notified the firm that they were distributed without agency clearance and m...

Human Drugs

GDUFA 3 Reauthorization Public Meeting Set

FDA sets a 7/21 virtual public meeting to hear comments on the GDUFA 3 reauthorization.

Animal Drugs

Adulterated, Misbranded Animal Drugs at Rapid Equine

FDA warns Rapid Equine Solutions that it is providing adulterated and misbranded compounded animal drugs.

Medical Devices

Robotic Exoskeleton Cleared for Brain Injury

FDA clears a Ekso Bionics 501(k) for the EksoNR robotic exoskeleton for use with patients with acquired brain injury.